[{"address1": "11085 Torreyana Road", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 558 0708", "fax": "858 558 0709", "website": "https://www.bioatla.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "BioAtla, Inc., a clinical-stage biopharmaceutical company, develops specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. The company's lead clinical stage product candidates include mecbotamab vedotin (BA3011), a conditionally active biologic (CAB) antibody-drug conjugate (ADC) for treating undifferentiated pleomorphic sarcoma and non-small cell lung cancer (NSCLC); and ozuriftabmab vedotin (BA3021), a CAB ADC to treat melanoma and squamous cell carcinoma of head and neck. It is also developing Evalstotug (BA3071), a CAB anti-cytotoxic T-lymphocyte-associated antigen 4 antibody for treating melanoma, renal cell carcinoma, colorectal cancer, and NSCLC; BA3182, a bispecific candidate to treat adenocarcinomas; BA3361, a CAB-Nectin-4-ADC for treating tumors; BA3142, a dual-CAB T-cell engager targeting B7-H3, a protein expressed on various solid tumors; and preclinical candidate for CAB-Nectin 4 x CAB-CD3. The company was founded in 2007 and is headquartered in San Diego, California.", "fullTimeEmployees": 61, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jay M. Short Ph.D.", "age": 66, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 1010378, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard A. Waldron", "age": 70, "title": "Senior VP & CFO", "yearBorn": 1954, "fiscalYear": 2024, "totalPay": 600800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Eric L. Sievers M.D.", "age": 60, "title": "Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 637775, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christian J. Vasquez CPA", "age": 48, "title": "Chief Accounting Officer, Controller and Corporate Secretary", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 408745, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Susie  Melody", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cathy  Chang Ph.D.", "title": "Senior Vice President of Research & Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Gerhard  Frey Ph.D.", "title": "Senior Vice President of Technology Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Monica  Sullivan", "title": "Senior Vice President of Intellectual Property & Contracts", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sheri  Lydick", "title": "Chief Commercial Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Lisa M. Pelton", "title": "Accounting Manager", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 7, "compensationRisk": 6, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1748736000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.3985, "open": 0.3985, "dayLow": 0.3955, "dayHigh": 0.4395, "regularMarketPreviousClose": 0.3985, "regularMarketOpen": 0.3985, "regularMarketDayLow": 0.3955, "regularMarketDayHigh": 0.4395, "payoutRatio": 0.0, "beta": 0.911, "forwardPE": -0.27306122, "volume": 632873, "regularMarketVolume": 632873, "averageVolume": 561596, "averageVolume10days": 498500, "averageDailyVolume10Day": 498500, "bid": 0.38, "ask": 0.5206, "bidSize": 71, "askSize": 2, "marketCap": 23449026, "fiftyTwoWeekLow": 0.24, "fiftyTwoWeekHigh": 2.525, "priceToSalesTrailing12Months": 2.1317296, "fiftyDayAverage": 0.4189, "twoHundredDayAverage": 0.952455, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -8359958, "profitMargins": 0.0, "floatShares": 44267515, "sharesOutstanding": 58418100, "sharesShort": 4237342, "sharesShortPriorMonth": 4297685, "sharesShortPreviousMonthDate": 1745971200, "dateShortInterest": 1748563200, "sharesPercentSharesOut": 0.0725, "heldPercentInsiders": 0.10416, "heldPercentInstitutions": 0.32915002, "shortRatio": 9.74, "shortPercentOfFloat": 0.08140001, "impliedSharesOutstanding": 58418100, "bookValue": 0.009, "priceToBook": 44.600002, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -61876000, "trailingEps": -1.22, "forwardEps": -1.47, "enterpriseToRevenue": -0.76, "enterpriseToEbitda": 0.126, "52WeekChange": -0.7429487, "SandP52WeekChange": 0.09544468, "quoteType": "EQUITY", "currentPrice": 0.4014, "targetHighPrice": 14.0, "targetLowPrice": 1.0, "targetMeanPrice": 8.33333, "targetMedianPrice": 10.0, "recommendationKey": "none", "numberOfAnalystOpinions": 3, "totalCash": 32363000, "totalCashPerShare": 0.554, "ebitda": -66232000, "totalDebt": 554000, "quickRatio": 2.022, "currentRatio": 2.345, "totalRevenue": 11000000, "debtToEquity": 101.28, "revenuePerShare": 0.215, "returnOnAssets": -0.65791, "returnOnEquity": -2.46209, "grossProfits": -45598000, "freeCashflow": -34481500, "operatingCashflow": -57396000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": -6.1, "financialCurrency": "USD", "symbol": "BCAB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "shortName": "BioAtla, Inc.", "regularMarketChangePercent": 0.72773, "regularMarketPrice": 0.4014, "corporateActions": [], "postMarketTime": 1750450218, "regularMarketTime": 1750449602, "exchange": "NGM", "messageBoardId": "finmb_105291463", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "longName": "BioAtla, Inc.", "ipoExpectedDate": "2020-12-16", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1608129000000, "postMarketChangePercent": 0.0, "postMarketPrice": 0.4014, "postMarketChange": 0.0, "regularMarketChange": 0.0029, "regularMarketDayRange": "0.3955 - 0.4395", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 561596, "fiftyTwoWeekLowChange": 0.1614, "fiftyTwoWeekLowChangePercent": 0.6725, "fiftyTwoWeekRange": "0.24 - 2.525", "fiftyTwoWeekHighChange": -2.1236, "fiftyTwoWeekHighChangePercent": -0.84102964, "fiftyTwoWeekChangePercent": -74.29487, "earningsTimestamp": 1746561900, "earningsTimestampStart": 1754510400, "earningsTimestampEnd": 1754942400, "earningsCallTimestampStart": 1746563400, "earningsCallTimestampEnd": 1746563400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.22, "epsForward": -1.47, "epsCurrentYear": -1.16, "priceEpsCurrentYear": -0.3460345, "fiftyDayAverageChange": -0.017500013, "fiftyDayAverageChangePercent": -0.04177611, "twoHundredDayAverageChange": -0.55105495, "twoHundredDayAverageChangePercent": -0.57856274, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "displayName": "BioAtla", "trailingPegRatio": null, "__fetch_time": "2025-06-21"}]